Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus dexamethasone in inferior alveolar nerve block for rebound pain after unilateral mandibulectomy
PACTR202502890179104Phase 0Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of dexmedetomidine and dexamethasone in cancer and postoperative pain (3 arms), sponsored by Mansoura University. Primary endpoint: Prevalence of postoperative rebound pain. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
dexmedetomidinedexamethasone
03
Conditions
cancerpostoperative pain
Beyond the preview
Go deeper on PACTR202502890179104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502890179104.